Characterization of proteins regulated by interleukin-4 in 3T3-L1 adipocytes by unknown
a SpringerOpen Journal
Shiau et al. SpringerPlus  (2015) 4:242 
DOI 10.1186/s40064-015-0980-0RESEARCH Open AccessCharacterization of proteins regulated by
interleukin-4 in 3T3-L1 adipocytes
Ming-Yuh Shiau1†, Hsu-Feng Lu2†, Yih-Hsin Chang3†, Yen-Chih Chiu3 and Yung-Luen Shih4,5,6*Abstract
Obesity is closely associated with metabolic syndrome, type 2 diabetes mellitus (T2DM) and cardiovascular diseases.
Our previous reports uncover the significant associations between interleukin-4 (IL-4)/IL-4 receptor genotypes and
T2DM, as well as IL-4 genotypes and high density lipoprotein-cholesterol. Theses observations suggest that IL-4
harbors the capacity to regulate lipid metabolism. The present study is aimed at further elucidating regulatory roles
of IL-4 to lipid metabolism by identifying putative proteins in 3T3-L1 adipocytes which are differentially expressed
under IL-4 treatment. Proteins in mature 3T3-L1 adipocytes with altered expression levels under IL-4 treatment
were identified by proteomic strategy. Our results revealed that IL-4 up-regulated levels of ATP synthase δ chain,
Cytochrome c reductase, Pyrophsphatase and Vimentin, whereas, Alpha-enolase, Gelsolin, Vinculin and Valosin were
down-regulated. These observations suggest that IL-4 promotes energy metabolism and inhibit lipid deposits in
adipocytes by up-regulating proteins accelerating ATP synthesis. Our results suggest that IL-4 facilitates adipocytes
metabolism to catabolism with a favorable condition for lipolysis. These catabolized lipids in adipocytes triggered by
IL-4 might either be released into periphery or metabolized intracellularlly, and modulate systemic energy metabolism.
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Obesity is characterized by excess accumulation of lipids
in intra-abdominal adipose tissue. The enlargement of
adipose tissue is a combination of increased cell number
(hyperplasia), size (hypertrophy) and formation (adipo-
genesis) of adipocytes (Cornelius et al. 1994; Sorisky
1999). Obesity has become an epidemic problem globally,
affecting persons of all ages in both developed and devel-
oping countries. In 2010, the World Health Organization
(WHO) estimated that about 2.1 billion adults were over-
weight (body Mass Index [BMI] > 25), and at least 400
million of them were obese (BMI > 30) (World Health
Organization 2014). Obesity is also the major risk factor
leading to insulin resistance and type 2 diabetes mellitus
(T2DM), with 44 % of the diabetic burden are attributable
to overweight and obesity. Moreover, overweight and
obesity are leading risks for global deaths, causing death* Correspondence: t005524@ms.skh.org.tw
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provided the original work is properly creditedtoll of 3.4 million adults each year. Therefore, obesity has
become an epidemic health problem due to its global
increasing prevalence and its close association with
multiple metabolic abnormalities.
Adipose tissue is an important endocrine organ that
secretes a variety of biologically active molecules (adipo-
kines) (Bradley et al. 2005; Trayhurn and Beattie 2001).
In addition to regulating energy metabolism, these adipo-
kines also take part in immune responses and cardiovas-
cular tone. Dysregulated production of these adipokines
is implicated in obesity and related metabolic conse-
quences (Chaldakov et al. 2003; Lyon et al. 2003). IL-6,
one of the type 2 T helper cell (Th2) cytokines with the
activity to specifically regulate Th1/Th2 balance, is ele-
vated in T2DM subjects (Paul and Seder 1994). Accord-
ingly, immune responses are suggested to play certain
roles in obesity and the closely related metabolic abnor-
malities. In this context, differentially expressed pro-
teins of adipocytes in response to external stimuli may
regulate adipocyte behavior and contribute to metabolic
abnormalities.
Interleukin-4 (IL-4) is another Th2 cytokine which
mediates Th1/Th2 balance and immune responses byle distributed under the terms of the Creative Commons Attribution License
hich permits unrestricted use, distribution, and reproduction in any medium,
.
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tors from macrophages (Paul 1997; Garcia-Zepeda et al.
1996; Kang et al. 2008). Our previous reports identified
the association between IL-4/IL-4R genotypes and T2DM,
as well as between IL-4 genotypes and high density
lipoprotein-cholesterol (HDL-C) (Ho et al. 2010; Chang
et al. 2012a). Our animal study reveals that IL-4 partici-
pates in lipid metabolism by inhibiting triglyceride accu-
mulation in fat tissues, which leads to decreased weight
gain and fat mass (Chang et al. 2012b). It suggests that
IL-4 is involved in diabetic susceptibility and complica-
tions through its capacity of regulating insulin sensitivity,
glucose tolerance and lipid metabolism. Our observations
echo the hypothesis from Elbe-Burger et al. that IL-4
participates in lipid metabolism (Elbe-Burger et al. 2002).
Our most recent report indicates that IL-4 harbors anti-
lipogenic ability by suppressing adipocytes differentiation
and promoting lipolysis in mature adipocytes (Tsao et al.
2014). The above results indicate that IL-4 regulates
energy metabolism by promoting catabolism rather than
energy storage through modulating adipocytes behaviors.
In this context, the aim of the present study is to
identify the effects of IL-4 on protein expression profiles
of adipocytes by proteomic strategy for further addressing
the role of IL-4 in metabolism and metabolic pathogen-
esis. Our results suggest that IL-4 potentiates adipocytes
metabolism to catabolism with a favorable condition for
lipid decomposition. These catabolized lipids in adipocytes
triggered by IL-4 might either be released into periphery
or metabolized intracellularlly, and subsequently modulate
systemic energy metabolism.Fig. 1 3T3-L1 pre-adipocytes were cultured for 8 days in the absence (a) o
O staining. The morphological characteristics of cells before and after differ
the amplified Oil-red O stating results of (b)Results and discussion
IL-4 has been suggested to participate in lipid metabolism
by inducing peroxisome proliferator-activated receptor-γ
expression in macrophages and monocytes (Ricote et al.
2000; Elbe-Burger et al. 2002). In support of the above
hypothesis, our previous study reveals that IL-4 promotes
lipolysis by boosting hormone sensitive lipase (HSL)
activity and translocation in adipocytes. It indicates that
the decrease of lipid deposits in adipocytes under IL-4
treatment results from the pro-lipolytic activity of IL-4
through modulating HSL activity to inhibit adipocytes
differentiation and lipid accumulation (Tsao et al. 2014).
For further addressing the roles of IL-4 in lipid metabol-
ism, the present study aimed at characterizing proteins
that are regulated by IL-4 in 3T3-L1 mature adipoctyes
by proteomic techniques.
For achieving our study goal, the cell model system for
3T3-L1 adipocytes differentiation was firstly established
as described (Tsao et al. 2014), and the extent of differ-
entiation was evaluated by Oil-Red O (ORO) staining
(Fig. 1). Dose response (10, 25 and 50 ng/mL) and time
course (30 min to 24 h) experiments of IL-4 treatment
in mature 3T3-L1 adipocytes were then examined to
exclude the potential influences of protein expression
patterns by cytotoxic effects induced by IL-4 for estab-
lishing optimal experimental condition. No apoptosis or
necrosis of 3T3-L1 cells were observed under IL-4 treat-
ment, and no significant difference in total amounts of
proteins was observed (data not shown). Then proteomic
analysis of putative immediate alterations in protein ex-
pression profiles in response to short term IL-4 treatmentr presence (b) of differentiation inducing agents, and subject to Oil-red
entiation were shown as (c) and (d), respectively; (e) and (f) showed
Shiau et al. SpringerPlus  (2015) 4:242 Page 3 of 6(30 min of 50 ng/mL IL-4) was analyzed. Figure 2 shows
the representative 2-dimensional electrophoretic results
of mature adipocytes protein expression profile in the
absence (A) or presence (B) of IL-4 treatment. Four pro-
teins that were reproducibly up-regulated by IL-4 treat-
ment in three separate experiments were characterized,
including Cytochrome c reductase, Pyrophosphatase, ATP
synthase δ chain and Vimentin (Table 1). On the contrary,
Valosin, Gelsolin, Alpha enolase (α-enolase) and Vinculin
were down-regulated by IL-4 (Table 1).
Among the IL-4 up-regulated proteins, genotypes of
mitochondrial ATP synthase subunit are reported to be
associated with T2DM pathogenesis (Guo et al. 2005).
DeLany et al. reveals that induction of ATP synthase δ
chain is accompanied by adipogenesis of adipose-derived
adult stem cells for promoting glycolysis and fatty acid
metabolism (DeLany et al. 2005). Accordingly, the up-
regulation of ATP synthase δ chain by IL-4 might result
in increased ATP synthesis which promotes adipocyte
metabolism. Activity of Pyrophosphatase is to hydrolyze
pyrophosphate and produce phosphates which in turn
participate in cellular activities such as DNA synthesis,
ATP production and signal transduction (Ishibashi et al.
2005). The increased levels of Pyrophospatase under IL-
4 treatment also support the above suggestion that IL-4
might facilitate lipid metabolism by promoting ATP pro-
duction. Cytochrome c reductase, a component of com-
plex I in mitochondrial electron transport chain, mediates
ATP production and proton release for energy supply
(Esteitie et al. 2005). The increased levels of Cytochrome c
reductase further implicate that efficiency of ATP produc-
tion may be increased in adipocytes in response to IL-4.
Vimentin is one of the important components of cytoskel-
eton involved in steroid synthesis (Azumi and Battifora
1987). Phosphorylation of Vimentin induces alterations of
cytoskeleton which promotes the interaction between lipidFig. 2 Representative 2-dimensional protein profiles of mature 3T3-L1 adip
in the absence (a) or presence of IL-4 treatment (b; 50 ng/mL for 30 min) w
SDS-PAGE) and visualized with silver staindroplets and mitochondria, and subsequently steroid
synthesis. Moreover, Vimentin is identified in intracellular
GLUT4-enriched membranes, suggesting its involvement
in glucose transport (Guilherme et al. 2000). Thus, the
IL-4-induced Vimentin might contribute to glucose trans-
porter trafficking and glucose uptake (Bluher et al. 2002).
Combining the above effects, IL-4 treatment seems to
promote adipocyte metabolism by increasing cellular ATP
levels.
On the contrary, levels of several proteins are decreased
by IL-4 treatment. Valosin is a member of ATPase protein
family (Yamamoto et al. 2004). Therefore, IL-4 might ele-
vate intracellular ATP levels by down-regulating Valosin
expression. Gelsolin is a Ca2+- and polyphosphoinositide-
modulated actin-binding protein which serves compli-
cated physiological functions, including regulation of lipid
metabolism (Yin et al. 1988). Interestingly, the functions
of Gelsolin are in turn regulated by various signaling
molecules, including a variety of lipids (Isenberg and
Goldmann 1995). Vinculin is another cytoskeleton-associ-
ated protein that functions in regulating cell adhesion
and motility by transducing force across cell membranes
(DeMali et al. 2002; Mere et al. 2005). The IL-4-
downregulated Gelsolin and Vinculin might be involved in
the regulation of cytoskeleton and secretory proteins. The
ubiquitous glycolytic enzyme α-enolase catalyzes the for-
mation of phosphoenolpyruvate from 2-phosphoglycerate,
one of the high-energy intermediates that generate ATP in
glycolysis (Pancholi 2001). Thus, α-enolase is an enzyme
with the functions of regulating glycolysis and cell growth
(Saulot et al. 2002). The expression of α-enolase is de-
creased by IL-4, which may result in decreased glycolysis
and pyruvate synthesis, and thus mediate glucose metab-
olism in adipocytes.
Taking the above observations together, most of the
IL-4 regulated proteins are related to or involved inocytes. Proteins (120 μg) from fully differentiated 3T3-L1 adipocytes
ere separated by 2-dimensional electrophoresis (pH 4–7, 9-15 %
Table 1 Differentially expressed proteins of mature 3T3-L1
adipocytes by IL-4 treatment





Cytochrome C reductase 53.4 1 BAB28666
Pyrophosphatase 33.1 3 Q9D819
ATP synthase D chain 18.6 4 ATPD MOUSE
Vimentin 53.7 8 CAA39807
Down-regulated
Vinculin 117 2 AAH08520
Valosin 80.6 5 Q8BNF8
Gelsolin 80 6 Q6PAC1
Alpha enolase 47.3 7 ENOA MOUSE
aEach score of above proteins is >62, and protein scores greater than 61 are
significant (p < 0.05)
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gests that the net effect of IL-4 treatment is to po-
tentiate the increase of ATP levels in adipocytes. The
results support our previous observation that adipo-
cytes metabolism might be deviated to catabolism by
IL-4 with a favorable condition for lipolysis and inhi-
biting adipogenesis (Tsao et al. 2014). The catabolized
lipids in adipocytes triggered by IL-4 might either be
released into periphery or metabolized intracellularlly,
and subsequently modulate systemic energy metabolism.
However, the underlying mechanism of IL-4 regulating
lipid metabolism awaits further investigation. Despite the
needs of further study, the protein alterations in adipo-
cytes under IL-4 treatment revealed in the present
study provide novel clues into the nature of the inter-
actions between immunological mediators and adipo-
cyte metabolism.
Conclusion
We previously reported significant associations between
interleukin-4 (IL-4)/IL-4 receptor genotypes and T2DM,
as well as IL-4 genotypes and HDL-C, which suggest the
involvement of IL-4 in lipid metabolism. For further
elucidating the role of IL-4 in regulating metabolism, the
present study aimed at characterizing the proteins regu-
lated by IL-4 in 3T3-L1 adipocytes. Our results revealed
that ATP synthase δ chain, Cytochrome c reductase, Pyr-
ophsphatase and Vimentin were up-regulated, whereas
α-enolase, Gelsolin, Vinculin and Valosin were down-
regulated by IL-4 treatment. IL-4 tends to increase intra-
cellular ATP levels and facilitate energy catabolism in
adipocytes by enhancing protein machinery which accel-
erates ATP synthesis. The results support our previous
inference which suggests the metabolism of adipocytes is
deviated to catabolism by IL-4 with a favorable condition
for lipolysis.Materials and methods
Cell culture and interleukin-4 treatment of 3T3-L1
adipocytes
3T3-L1 pre-adipocytes were maintained in DMEM con-
taining 10 % calf serum in an atmosphere of 5 % CO2 at
37 °C. Differentiation of post-confluent cells was initiated
by incubation with 0.25 mM dexamethasone, 0.5 mM 3-
isobutyl-1-methylxanthine and 10 ug/mL insulin for 48 h
(Tsao et al. 2014; Hua et al. 2004). Then cells were cultured
in DMEM supplemented with 10 % fetal bovine serum and
insulin for the next 4–10 days to fully differentiate. Mature
3T3-L1 adipocytes were treated with 50 ng/mL recombin-
ant IL-4 (Millipore) for 30 min after 2 h of serum starva-
tion, then cell lysates were harvested and the protein
expression profiles were examined as described below.
Oil Red O staining
Lipid accumulation during 3T3-L1 differentiation was
confirmed by Oil Red O staining. Cells were washed
twice with phosphate buffered saline, fixed in 10 %
formalin neutral buffered solution for 10 min at room
temperature, rinsed with distilled water and dried after
they were induced. Then cells were stained with Oil Red
O (composed of 0.6 % Oil Red O dye dissolved in isopro-
panol and water, 6:4) for 30 min and washed with
distilled water (Tsao et al. 2014; Madsen et al. 2003). The
results showed that over 90 % of cells exhibited typical
mature adipocytes morphology after 8 days of induction.
Proteomic techniques
After cells were treated with IL-4, cell lysates were
obtained with lysis buffer containing protease inhibitors
(8 M urea, 4 % 3-[(3-cholamidopropyl)dimethylammo-
nio]-1-propanesulfonate [CHAPS], 1 mM phenylmethyl-
sulfonyl fluoride [PMSF] and 100 ug/uL leupeptin) for
30 min on ice, then sonicated by 10 s interval for 3 times.
The sonicated cell lysates were frozen at −20 °C for
30 min, and dried out using speed vacuum. The dried cell
lysates were re-solubilized in lysis buffer, centrifuged with
11,000 rpm for 30 min at 18 °C. Then supernatant were
collected and the proteins in cell lysates were separated by
isoelectric focusing (with pH range 4–7) and 9 ~ 15 %
gradient SDS-PAGE electrophoresis sequentially. The
2-dimensional electrophoresis gel containing separated
proteins was visualized by sliver staining, then the protein
spots that showed great alterations before and after IL-4
treatment were cut and washed by sterile distilled water,
followed by 50 mM NH4HCO3/100 % acetone nitrite
(v/v: 3:2), and de-stained with 0.1 g K3Fe(CN)6 plus so-
dium thiosulfate solubilized in 50 ml distilled water. The
cut gel particles were washed by 25 mM NH4HCO3 and
100 % acetonitrite for dehydration, and soaked in trypsin
overnight for in gel digestion, then each sample was
applied on the anchor chip for MALDI-TOF analysis.
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MALDI-TOF analysis was conducted as previously
described (Wang et al. 2002). Briefly, tryptic peptide
solutions were mixed with an equal amount of CHCA
matrix (10 mg/mL in 60 % cetonitrite/0.3 % trifluoroace-
tic acid), spotted onto the sample plates and air-dried.
Reflectron mass spectrometric analyses were performed
in the Proteomics Core Laboratory in Chang Gung
University. Acquired spectra were searched against
MASCOT databases. A positive score was defined to be
greater than 62 for each peptide ion. Proteins were
identified based on multiple matches to peptides from
the same protein by MASCOT score.
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